移植用HLA分型市场－全球产业规模、份额、趋势、机会及预测，依产品及服务、技术、应用、移植类型、地区及竞争格局划分，2020-2030年预测

2024年全球移植用HLA分型市场规模为19.2亿美元，预计2030年将以6.91%的复合年增长率成长至28.7亿美元。移植以人类白血球抗原（HLA）分型是一种分子诊断过程，透过识别特定的HLA基因和蛋白质来确定器官和干细胞供体与受体之间的相容性，从而最大限度地减少免疫排斥反应并提高移植成功率。

主要市场驱动因素

全球对器官和干细胞移植的需求不断增长，显着推动了人类白血球抗原（HLA）分型市场的发展。末期肾病、肝衰竭和各种血液系统恶性肿瘤等慢性疾病的日益普遍，使得这些挽救生命的治疗手段变得尤为重要。

主要市场挑战

全球范围内持续存在的相容性供体器官短缺严重阻碍了全球人类白血球抗原（HLA）分型移植市场的扩张。 HLA分型的基础需求与移植手术的数量密切相关，因为这些诊断检测对于评估捐赠者与受体的相容性以及降低免疫排斥反应至关重要。

主要市场趋势

人工智慧在人类白血球抗原（HLA）资料分析中的应用日益广泛，提高了移植供体-受体匹配的精确度。人工智慧演算法能够高效处理海量基因组资料，实现复杂的模式识别和预测建模，这对于应对HLA基因复杂的遗传多态性至关重要。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球HLA分型移植市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品和服务分类（试剂和耗材、仪器、软体和服务）
  • 依技术分类（分子检测技术、非分子检测技术）
  • 依应用领域（诊断应用、抗体筛检、嵌合体监测、研究应用、其他）
  • 依移植类型（实体器官移植、软组织移植）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美HLA分型移植市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲HLA分型在移植的应用市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区HLA分型在移植的应用市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲HLA分型在移植市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲HLA分型移植市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球移植用HLA分型市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Qiagen NV
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd
• Immucor, Inc.
• Caredx. Inc.
• Luminex Corporation (Diasorin)
• Tbg Diagnostics Limited

第十六章：策略建议

第17章调查会社について・免责事项

The Global HLA Typing for Transplant Market, valued at USD 1.92 Billion in 2024, is projected to experience a CAGR of 6.91% to reach USD 2.87 Billion by 2030. Human Leukocyte Antigen (HLA) typing for transplant is a molecular diagnostic process identifying specific HLA genes and proteins to determine compatibility between organ and stem cell donors and recipients, thereby minimizing immune rejection and enhancing transplant success.

Key Market Drivers

The escalating global demand for organ and stem cell transplants significantly propels the Human Leukocyte Antigen typing market. The rising prevalence of chronic diseases like end-stage renal disease, liver failure, and various hematologic malignancies necessitates these life-saving procedures. This increasing demand directly translates into a greater need for precise HLA compatibility assessment to ensure successful engraftment and minimize rejection rates.

Key Market Challenges

The persistent global shortage of compatible donor organs significantly impedes the expansion of the Global Human Leukocyte Antigen typing for transplant market. The foundational demand for HLA typing is intrinsically linked to the volume of transplant procedures performed, as these diagnostic tests are essential for assessing donor-recipient compatibility and mitigating immune rejection. A scarcity of available organs directly limits the number of potential transplant surgeries, thereby reducing the overall requirement for HLA typing.

Key Market Trends

The increasing application of Artificial Intelligence in Human Leukocyte Antigen data analysis is enhancing the precision of donor-recipient matching for transplantation. AI algorithms efficiently process extensive genomic data, enabling sophisticated pattern recognition and predictive modeling essential for navigating the complex polymorphism of HLA genes. This capability directly improves transplant success rates by identifying optimal matches and mitigating immune complications.

Key Market Players

• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Qiagen N.V.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd
• Immucor, Inc.
• Caredx. Inc.
• Luminex Corporation (Diasorin)
• Tbg Diagnostics Limited

Report Scope:

In this report, the Global HLA Typing for Transplant Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

HLA Typing for Transplant Market, By Product & Service:

• Reagents & Consumables
• Instruments
• Software & Services

HLA Typing for Transplant Market, By Technology:

• Molecular Assay Technologies
• Non-molecular Assay Technologies

HLA Typing for Transplant Market, By Application:

• Diagnostic Applications
• Antibody Screening
• Chimerism Monitoring
• Research Applications
• Others

HLA Typing for Transplant Market, By Transplant Type:

• Solid Organ Transplant
• Soft Tissue Transplant

HLA Typing for Transplant Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global HLA Typing for Transplant Market.

Available Customizations:

Global HLA Typing for Transplant Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global HLA Typing for Transplant Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Service (Reagents & Consumables, Instruments, Software & Services)
  • 5.2.2. By Technology (Molecular Assay Technologies, Non-molecular Assay Technologies)
  • 5.2.3. By Application (Diagnostic Applications, Antibody Screening, Chimerism Monitoring, Research Applications, Others)
  • 5.2.4. By Transplant Type (Solid Organ Transplant, Soft Tissue Transplant)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America HLA Typing for Transplant Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Service
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By Transplant Type
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States HLA Typing for Transplant Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Service
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Transplant Type
  • 6.3.2. Canada HLA Typing for Transplant Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Service
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Transplant Type
  • 6.3.3. Mexico HLA Typing for Transplant Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Service
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Transplant Type

7. Europe HLA Typing for Transplant Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Service
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By Transplant Type
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany HLA Typing for Transplant Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Service
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Transplant Type
  • 7.3.2. France HLA Typing for Transplant Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Service
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Transplant Type
  • 7.3.3. United Kingdom HLA Typing for Transplant Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Service
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Transplant Type
  • 7.3.4. Italy HLA Typing for Transplant Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Service
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Transplant Type
  • 7.3.5. Spain HLA Typing for Transplant Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Service
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Transplant Type

8. Asia Pacific HLA Typing for Transplant Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Service
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By Transplant Type
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China HLA Typing for Transplant Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Service
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Transplant Type
  • 8.3.2. India HLA Typing for Transplant Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Service
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Transplant Type
  • 8.3.3. Japan HLA Typing for Transplant Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Service
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Transplant Type
  • 8.3.4. South Korea HLA Typing for Transplant Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Service
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Transplant Type
  • 8.3.5. Australia HLA Typing for Transplant Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Service
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Transplant Type

9. Middle East & Africa HLA Typing for Transplant Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Service
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By Transplant Type
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia HLA Typing for Transplant Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Service
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Transplant Type
  • 9.3.2. UAE HLA Typing for Transplant Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Service
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Transplant Type
  • 9.3.3. South Africa HLA Typing for Transplant Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Service
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Transplant Type

10. South America HLA Typing for Transplant Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Service
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By Transplant Type
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil HLA Typing for Transplant Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Service
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Transplant Type
  • 10.3.2. Colombia HLA Typing for Transplant Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Service
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Transplant Type
  • 10.3.3. Argentina HLA Typing for Transplant Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Service
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Transplant Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global HLA Typing for Transplant Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Illumina, Inc.
• 15.3. Qiagen N.V.
• 15.4. Bio-Rad Laboratories, Inc.
• 15.5. F. Hoffmann-La Roche Ltd
• 15.6. Immucor, Inc.
• 15.7. Caredx. Inc.
• 15.8. Luminex Corporation (Diasorin)
• 15.9. Tbg Diagnostics Limited

16. Strategic Recommendations

17. About Us & Disclaimer